Emergo by UL Human Factors Specialists discuss the specific requirements the National Medical Products Association (NMPA) has set forth for known problems analyses.
Are you a medical device manufacturer doing business in Europe? Learn more about European Medical Device Nomenclature and why is it important for medical device manufacturers.
Medical device manufacturers who want to better understand U.S. FDA warning letters should read our regulatory insight.
Medical device manufacturers can read our summary of the 2024 Annual Report recently released by the U.S. FDA’s Center for Devices and Radiological Health.
The U.S. Food & Drug Administration has finalized guidance requiring manufacturers to notify it of discontinuations or meaningful interruptions in manufacturing for many devices during, or in advance of, a public health emergency.
Our senior human factors engineering (HFE) and design experts answer questions about how to strategically approach discovery and design activities early on in product development.
The Medicines and Healthcare products Regulatory Agency (MHRA) announced the release of a suite of post-market surveillance (PMS) guidance (January 15).
This agreement paves the way for facilitating medical device market access for manufacturers between Malaysia and China.
Are you a manufacturer applying to register a medical device or IVD with the Australian Register of Therapeutic Goods (ARTG)? Now you have more options to fulfill the Manufacturer Evidence requirement to support an application.
Emergo by UL offers digital applications, human factors engineering (HFE) platform, Optimal Product Usability Suite (OPUS) and Regulatory Affairs Management Suite, RAMS.